MarketPeel
Insider Trading Intelligence
SR

Srikanth Radhakrishnan

LUNG
CHIEF SCIENCE &TECHN. OFFICER · PULMONX CORP · CIK 0002098678
FILING MIX · LIFETIME11%/89%
BUYS
1
SELLS
8
TOTAL VALUE
$37.3K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
343,045
AVG SELL PX
$1.49
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Srikanth Radhakrishnan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%+19.34%-1.18%+20.53%+20.53%
14d4+0.00%+5.57%-2.53%+8.10%+8.10%
30d4+100.00%-16.07%-4.54%-11.53%-11.53%
60d4+100.00%-11.47%+4.99%-16.47%-16.47%
90d4+0.00%+8.20%
180d4(4 pending)
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LUNG · 343,045 shares · as of Jun 1, 2026
086,434172,868259,302345,736SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 1 buys / 8 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
2,691$1.54$4.1K343,045Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
5,969$1.54$9.2K331,239Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
2,153$1.54$3.3K340,892Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
3,684$1.54$5.7K337,208Jun 1, 2026Jun 3, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
2,461$1.43$3.5K174,934Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
PURCHASEGRANT
Stock grant
175,000345,736Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
756$1.43$1.1K180,463Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
4,198$1.43$6.0K170,736Mar 2, 2026Mar 4, 2026View →
LUNG
PULMONX CORP
SALE
Chief Science &Techn. Officer
3,068$1.43$4.4K177,395Mar 2, 2026Mar 4, 2026View →
Other insiders · LUNG
Loading peer insiders…
About this filer
CIK 0002098678
ROLE
Chief Science &Techn. Officer
PRIMARY
LUNG
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002098678DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback